Bioequivalency, Branding, Life Science and Marketing

Search:

DAY

WEEK

MONTH

YEAR

Select your country:
Sign up | Log in

Bioequivalency

Branding

Life Science

Marketing

The Mesh of the Generics and the Potential of Emerging Therapies in the Smoking Cessation Market

Delveinsight

FEBRUARY 5, 2021

According to the CDC, in 2018, tobacco companies spent over USD 9 Billion in just promoting and marketing their cigars and cigarettes in the US. Smoking Cessation: What are the drugs available in the market? Chantix is also available in the EU and Japanese Smoking Cessation market. Generics in the Market.

Marketing

Marketing FDA Approval Branding Production

Biosimilars vs. Interchangeable Biological Products: FDA Fact Check

XTalks

FEBRUARY 8, 2021

Like generic forms of synthetic pharmaceuticals, biosimilars have the advantage of being less costly compared to their branded counterparts. To date, the FDA has approved 29 biosimilars, 19 of which are currently being marketed. MYTH: Clinical pharmacology studies of biosimilars aim to establish safety and effectiveness.

Production

Production Insulin Branding Generic Drugs

Clinical Research Informer

The Mesh of the Generics and the Potential of Emerging Therapies in the Smoking Cessation Market

Biosimilars vs. Interchangeable Biological Products: FDA Fact Check

Stay Connected